VitaHEAT Medical® and Ximedica Complete Initial Development Phase for the First Disposable Conductive Ink Patient Warming System

Tuesday, August 28, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

DEER PARK, Ill., Aug. 28, 2018 /PRNewswire/ -- VitaHEAT Medical®, LLC, a privately held medical device company and maker

of the reusable conductive VitaHEAT UB3 patient warming system, today announced with Ximedica® the completion of the initial product development phase for the first disposable patient warming system using patented conductive ink technology.  The next
generation of VitaHEAT's technology will deliver a safe, effective and easy to use product portfolio designed to meet all requirements for hospital and surgery center patient surface warming needs.  Currently two-thirds of the $1.8 billion patient surface warming global market use disposable convective (forced-air warming) products, which have recently come under pressure in lawsuits claiming that forced-air warming blankets used in surgery led to serious infections and required another surgery or amputation.

"We see opportunities to improve safety and efficacy and are excited about bringing the first conductive ink disposable patient warming solution to the market," said Peter Farmakis, President and CEO of VitaHEAT Medical®.  "We have seen consistent year-over-year sales growth with our VitaHEAT UB3 reusable patient warming device.  Many customers prefer the reusable VitaHEAT UB3 to warm their patients throughout the perioperative process (pre-op, intra-op and post-op) because it is safe, effective and easy to use.  However, some hospitals and surgery centers prefer disposables, and our next generation patient warming system will fill that need."

With 30 years of experience delivering innovative solutions to the medical device market, Ximedica focuses on human-centric design that translates user needs into meaningful, measurable specifications that result in a product that is safe and effective. 

"We completed the initial phase of product development with VitaHEAT. We are excited to continue this effort with them and successfully bring this next generation product to market," said Peter Thier, Executive Vice President, Ximedica.

About VitaHEAT Medical®, LLCVitaHEAT Medical® is a privately held medical device company dedicated to continually providing innovative patient warming solutions to reduce health care costs and improve patient outcomes.  The VitaHEAT UB3, the third version of the underbody patient warming system based on patented conductive ink technology, was launched in April of 2016 and has had consistent growth in annual sales.  The company is headquartered in Deer Park, Ill.  For more information, please visit www.vitaheatmedical.com.

About Ximedica®Ximedica® is a full-service ISO 13485-certified and FDA-registered company.  Ximedica leads the industry in some of the most groundbreaking medical product development.  Ximedica's product solutions improve the lives of patients, caregivers and clinicians every day.  For the last 30 years, Ximedica has provided a unique growth platform that enables its clients to successfully design, develop, and manufacture advanced medical technology products.   Ximedica has its headquarters in Providence, R.I., and offices in Hong Kong, Minneapolis, San Francisco, and Silicon Valley.  For more information, please visit www.ximedica.com.

If you would like more information about this topic, please call Robin Wedell at 800-850-8350 or email rwedell@vitaheatmedical.com.

FOR MORE INFORMATION Robin Wedell, VitaHEAT Medical®, LLCrwedell@vitaheatmedical.com 800-850-8350

 

Cision View original content:http://www.prnewswire.com/news-releases/vitaheat-medical-and-ximedica-complete-initial-development-phase-for-the-first-disposable-conductive-ink-patient-warming-system-300703073.html

SOURCE VitaHEAT Medical, LLC



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store